PharmaMar announce lurbinectedin achieves primary endpoint for SCLC
Madrid-headquartered pharmaceutical company PharmaMar has announced positive results for its Phase II trial of lurbinectedin as a monotherapy for relapsed...
Focus:
-
![ICR scientists find triple combination stops drug resistance in bowel cancer]()
ICR scientists find triple combination stops drug resistance in bowel cancer
-
![How government policy has shaped China’s pharma phenomenon]()
How government policy has shaped China’s pharma phenomenon
-
![Genomics England signs immunotherapy partnership with CCG]()
Genomics England signs immunotherapy partnership with CCG
-
![Biogen and Eisai terminate trial of Alzheimer’s drug on efficacy grounds]()
Biogen and Eisai terminate trial of Alzheimer’s drug on efficacy grounds
-
![Pharma Technology Focus: the absence of antivenom in pharma]()
Pharma Technology Focus: the absence of antivenom in pharma
-
![Celgene signs $25m AI drug discovery partnership with Exscientia]()
Celgene signs $25m AI drug discovery partnership with Exscientia
Expert commentary & analysis from GlobalData
Paclitaxel-coated devices under close watch by FDA following long-term, follow-up data
Myovant’s supposed market edge in castrate-sensitive prostate cancer draws reservations
Universal flu vaccine development is key to WHO 2030 strategy
Why are women more prone to arthritis than men?
Most Read
Company releases
Polpharma B2B Announces New Vice-President
Simon Clark has joined Polpharma as vice-president of the management board and chief commercial officer of Polpharma Group.
Alconox to Attend Interphex
Distek
INTERPHEX is a premier pharmaceutical, biotechnology and medical device development and manufacturing event where you can experience science through commercialisation.
Weiss Technik in the UK: Our Vision for the Future.
Master Your Supply Chain with TSS at LogiPharma
Come visit TSS in booth #60 at LogiPharma.
Company whitepapers
BIOne Bioprocess Control Station
DistekLife Science Products for the Pharmaceutical Industry
Weiss TechnikTemperature Check for Pharmaceutical Supply Chains
TSSTroubleshooting Tablet Defects in No Time
MedelpharmPolpharma Finished Dosage Formulation Dossier – Under Development
Polpharma B2BThermal Shipping Technologies: The Cold Hard Facts
TemptimeAscorbic Acid Tablet, Direct Compression Product Leaflet
SigachiCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Cellectis’ Cellular Therapies Manufacturing Facility, Raleigh, North Carolina
Cellectis is building a new facility named Innovative Manufacturing Plant for Allogeneic Cellular Therapies (IMPACT) in Raleigh, North Carolina, US.
Amicus Therapeutics’ Global Research and Gene Therapy Centre, Philadelphia
AveXis Gene Therapy Manufacturing Facility, North Carolina, US
Rubius Therapeutics’ Pharma Manufacturing Facility, Rhode Island, US
Catalent’s Biologics Manufacturing Facility Expansion, Bloomington, Indiana, US
Clinical Trials
Biogen and Eisai terminate trial of Alzheimer’s drug on efficacy grounds
Biogen and Eisai have announced they are discontinuing two Phase III trials, Engage and Emerge, evaluating the safety and efficacy of aducanumab in patients with...
EMA publishes safety warning for Pfizer’s Xeljanz in rheumatoid arthritis
GSK announces positive data for endometrial cancer drug dostarlimab
FDA approves Roche’s Tecentriq for fourth oncology indication
FDA expands label for Allergan’s antibacterial Avycaz
Drug Development
ICR scientists find triple combination stops drug resistance in bowel cancer
Scientists from the Institute of Cancer Research (ICR), London, have discovered how bowel cancer cells become resistant to targeted drugs, as well as finding that...
Study finds new drug combo could treat paediatric brain tumour
Biogen and Eisai terminate trial of Alzheimer’s drug on efficacy grounds
Takeda and HemoShear to develop new liver disease drugs
Celgene signs $25m AI drug discovery partnership with Exscientia
Market Data
UK MHRA recalls more batches of sartan medication
The UK Medicines and Healthcare Products Regulatory Agency has recalled three more batches of Losartan tablets amid fears of contamination with NMBA.
European pharma body warns of Brexit drug supply risk to EU
Novo Nordisk settles Victoza patent dispute with Teva in US
US Senate invites pharmacy benefit managers to testify on drug pricing
Brussels aims to attract UK pharma business post-Brexit
Technology
NASA calls for new vaccinations to combat virus reactivation during spaceflight
Researchers from NASA’s Johnson Space Center have discovered that dormant herpes viruses reactivate during spaceflight, leading to an urgent need to develop counter-measures, including vaccination,...
Microsoft unveils new platform to boost therapeutics production
Beam Therapeutics raises $135m to advance CRISPR technologies
CEPI joins forces with CureVac for vaccine printing platform
AI datathon helps repurpose five new candidates for chronic pancreatitis
Go Top